glp 1 glucose dependent insulin secretion Mechanism of glucose-dependent, GLP1-potentiated in GLP-1 receptor activated insulin secretion
Description
Some of the most meaningful questions around danuglipron still have not been answered, Jefferies analyst Akash Tewari said in a note to investors
This cognitive benefit is especially relevant for T2DM patients with PD, as cognitive decline is a common symptom in both conditions
the SURMOUNT-1 trial reported up to 22% with tirzepatide over 72 weeks
This happened just in the next 3 years
"Insurance Coverage, Type of Employment Shape Inequities in Access to Semaglutide." January 21, 2025
Sardeli AV, et al
